Effector analogues detect varied allosteric roles for conserved protein-effector interactions in pyruvate kinase isozymes

Biochemistry. 2011 Mar 22;50(11):1934-9. doi: 10.1021/bi200052e. Epub 2011 Feb 14.

Abstract

The binding site for allosteric inhibitor (amino acid) is highly conserved between human liver pyruvate kinase (hL-PYK) and the rabbit muscle isozyme (rM(1)-PYK). To detail similarities/differences in the allosteric function of these two homologues, we quantified the binding of 45 amino acid analogues to hL-PYK and their allosteric impact on affinity for the substrate, phosphoenolpyruvate (PEP). This complements a similar study previously completed for rM(1)-PYK. In hL-PYK, the minimum chemical requirements for effector binding are the same as those identified for rM(1)-PYK (i.e., the l-2-aminopropanaldehyde substructure of the effector is primarily responsible for binding). However, different regions of the effector determine the magnitude of the allosteric response in hL-PYK vs rM(1)-PYK. This finding is inconsistent with the idea that allosteric pathways are conserved between homologues of a protein family.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Allosteric Regulation
  • Amino Acids / chemistry*
  • Amino Acids / metabolism
  • Animals
  • Binding Sites
  • Humans
  • Isoenzymes / chemistry
  • Isoenzymes / metabolism
  • Kinetics
  • Liver / enzymology
  • Protein Conformation
  • Pyruvate Kinase / chemistry*
  • Pyruvate Kinase / metabolism
  • Rabbits

Substances

  • Amino Acids
  • Isoenzymes
  • Pyruvate Kinase